Yes, Cycrin tablets may be taken while traveling, but you should carry a copy of the prescription and keep the medication in its original packaging. Some countries may require documentation for prescription-only medicines, so it is advisable to check the destination’s import rules before departure.
The tablet formulation contains common excipients such as lactose, magnesium stearate, and microcrystalline cellulose. If you have known hypersensitivity to any of these substances, discuss alternatives with your clinician.
Cycrin is distinguished by its specific dosage strengths (5 mg and 10 mg) and tablet formulation. While the active ingredient, medroxyprogesterone, is shared across brands, differences in excipients, tablet size, and manufacturer may affect tolerability for some patients.
Medroxyprogesterone is not typically screened for in standard workplace or athletic drug tests. However, if a specific hormone panel is requested, the presence of a progestogen could be reported. Always disclose all medications to the testing authority if required.
Cycrin is not recommended during breastfeeding because medroxyprogesterone is excreted in breast milk and may affect the infant. Alternative treatments should be considered in consultation with a healthcare professional.
Heavy or prolonged bleeding warrants prompt medical evaluation. Contact your prescriber or seek urgent care to rule out serious complications such as endometrial pathology or thromboembolic events.
Dietary factors have minimal impact on Cycrin absorption, but a high-fat meal may slightly increase its bioavailability. Consistency in taking the tablet with the same type of meal (or none) each day helps maintain stable drug levels.
Certain herbal products, such as St. John’s wort, can induce CYP3A4 and potentially lower medroxyprogesterone concentrations, reducing therapeutic effect. Inform your healthcare provider about all supplements you are taking.
The duration of treatment depends on the underlying condition. For endometriosis, therapy may extend for several months to years under medical supervision, whereas short-term use for menstrual irregularities may last only a few cycles. Regular review with your clinician determines the appropriate length of therapy.
Brand-named Cycrin may be priced higher than generic medroxyprogesterone tablets due to branding and manufacturing costs. NHS prescription charges apply unless you qualify for exemptions. For exact pricing, consult your pharmacy or NHS prescription service.
Cycrin is a brand-name medication that contains the synthetic progestogen medroxyprogesterone as its active ingredient. It is supplied as oral tablets (pill form) in 5 mg and 10 mg strengths. In the United Kingdom, Cycrin is a prescription-only medicine (POM) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). The drug is classified within women’s health therapies and is used to modify hormonal activity in a range of gynecological conditions.
Medroxyprogesterone belongs to the class of synthetic progestogens, which mimic the actions of natural progesterone. After oral ingestion, the tablet is absorbed from the gastrointestinal tract and binds to progesterone receptors throughout the endometrium, breast tissue, and the central nervous system. Activation of these receptors:
The onset of hormonal effects typically occurs within a few days, with peak plasma concentrations reached in about 2-4 hours after a single dose. Medroxyprogesterone is metabolised primarily by the liver enzyme CYP3A4 and has a half-life of roughly 12-15 hours, allowing once-daily dosing.
Cycrin is approved by the MHRA for the following indications in adult women:
These approved uses are based on the drug’s ability to provide progestogenic protection against unchecked estrogen stimulation of the uterine lining.
This article provides educational information about Cycrin and is not a substitute for professional medical advice. Treatment decisions, including the use of any medication for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes only and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
